Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.
about
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetesA staged screening of registered drugs highlights remyelinating drug candidates for clinical trialsInfection in systemic lupus erythematosus: friend or foe?BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease.Do early childhood immunizations influence the development of atopy and do they cause allergic reactions?Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.Does the "hygiene hypothesis" provide an explanation for the high prevalence of multiple sclerosis in Sardinia?EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy.Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium Tuberculosis and Modulates Autoimmune Encephalomyelitis.Mycobacterium bovis bacille Calmette-Guérin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner.Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNSMycobacteria-induced suppression of autoimmunity in the central nervous system.The human microbiome in multiple sclerosis: pathogenic or protective constituents?Vaccination against infection in patients with multiple sclerosis.Vitamin D and Parkinson's disease.The interplay between bacillus Calmette-Guérin and Treg cells and its role to prevent or cure inflammatory diseases.Noise in multiple sclerosis: unwanted and necessary.Immune evasion, immunopathology and the regulation of the immune system.Trained immunity: consequences for the heterologous effects of BCG vaccination.TNF, TNF Inducers and TNFR2 Agonists: A New Path to Type 1 Diabetes Treatment.Vaccines in Multiple Sclerosis.Vaccines and multiple sclerosis: a systematic review.Conflicting Role of Mycobacterium Species in Multiple Sclerosis.BCG and protection against inflammatory and auto-immune diseases.[Vaccination and multiple sclerosis].Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.The adaptation model of immunity.Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations.
P2860
Q21134119-1B48B21E-A54A-4736-8CD8-4772F40E06C4Q30844551-91A7A994-977E-42E6-AEC9-369DE876B547Q33696879-DAF14071-EBFB-467A-8B11-521BF908C959Q33815568-3B59E071-330E-494A-A073-ACBCAF0F1B94Q34532620-59EC4A4E-7B19-4FE8-91B3-561666AB8191Q35140351-7AE05501-8D5E-4DB2-86CC-19A7305399F5Q35563668-AAC80666-D666-4CF2-8B71-54CD4DA7B639Q35597330-42B0F10F-CF17-4633-91F6-792E2FB48E56Q36930224-DA117554-743B-4EF0-A3AE-A1113A38FC77Q37327197-2604C6DF-54D1-4D28-8C9A-16DA3937AA43Q37415788-F174716B-D109-49A7-9E08-7C2DED584FB9Q37718078-68009D48-95B6-42E0-ADBF-D01976ADB9CBQ37830018-00A2FD76-8777-4759-83A9-97822FF94E6CQ37978121-6BFB14DC-E099-4E69-BD94-76C870855173Q38038831-5B8F5E48-D0D2-4CF8-B943-5F21142A7BBCQ38212488-FA6CEABE-2A42-487A-A8DF-B0894F710134Q38263875-FFD7DE74-A2A7-47CF-AE73-BD3691C84E4BQ38273200-F5BEE9EA-6D75-44A0-844B-A13B2A199E00Q38312182-92034421-84DF-496B-AE3D-2B3B60D1D368Q38607412-E3653BD9-9157-40AE-ABDF-154177342196Q38752982-3317536F-BFE5-48F7-A4AE-DBDF2717E9A4Q38948785-F9202661-C69D-4F5A-9AA3-DFE102977500Q39349951-5B3BB33A-2377-42AF-ACFA-646A29DA91E9Q40203403-3E6F8042-2550-42F9-9697-DCD91392AC08Q40376451-7E0D1289-15B6-48EA-8F80-C6EFB933AA86Q44578009-5411FCFE-250B-42CD-A092-019DE147D0E8Q44991707-92ECB6E5-FE24-47E9-9F97-F966FDF8F425Q55290300-D5BFA95A-9B94-4710-ACE2-A2FDC27AEB45
P2860
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.
@ast
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.
@en
type
label
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.
@ast
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.
@en
prefLabel
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.
@ast
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.
@en
P2093
P356
P1433
P1476
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.
@en
P2093
Bastianello S
Buttinelli C
Colonnese C
Pozzilli C
Ruggieri S
Sabatini U
Salvetti M
P304
P356
10.1212/WNL.53.7.1588
P407
P577
1999-10-01T00:00:00Z